Chronic Kidney Disease News

Novartis announced that the company has agreed to acquire Chinook Therapeutics to expand its renal pipeline, according to a company press release.

The FDA on Tuesday approved letermovir for the prevention of cytomegalovirus disease in high-risk adult kidney transplant recipients, Merck announced.

The Federal Trade Commission has sued to stop Amgen from acquiring Horizon Therapeutics, a potential blockbuster deal that could restrict marketplace competition, according to an FTC press release.

The FDA has approved the 20 mg version of nitisinone used to treat hereditary tyrosinemia, according to a press release.

The FDA has approved sotagliflozin, a dual SGLT1/SGLT2 inhibitor, for reduction of risk for death, HF hospitalization and urgent HF visits in patients with HF and in those with certain CV risk factors, Lexicon Pharmaceuticals announced.

With May serving as Mental Health Awareness Month, Healio spoke with experts to discuss how nephrologists and dialysis staff can improve the mental health of patients with kidney disease.

This year, the national virtual camp hosted by the American Kidney Fund will include a program specifically for children with cystinosis.

Researchers identified the most accurate estimate of measured glomerular filtration rate is derived from the lower eGFR between creatinine-based eGFR and cystatin C-based eGFR in older adults, according to data published in Kidney Medicine.

Compared with patients on dialysis who received amoxicillin-based treatment, those who received azithromycin treatment were at an increased risk for sudden cardiac death, according to data published in Kidney Medicine.

Patients with chronic kidney disease and obesity may be at a higher risk for death when experiencing BMI loss at the same time as serum albumin or fat-free mass loss, according to data published in Kidney International Reports.